Bausch + Lomb Corporation (BLCO)

USD 11.5

(-0.78%)

Inventory Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual inventory in 2023 was 1.02 Billion USD , up 63.69% from previous year.
  • Bausch + Lomb Corporation's latest quarterly inventory in 2024 Q3 was 1.11 Billion USD , up 4.68% from previous quarter.
  • Bausch + Lomb Corporation reported annual inventory of 628 Million USD in 2022, up 9.79% from previous year.
  • Bausch + Lomb Corporation reported annual inventory of 572 Million USD in 2021, down -7.14% from previous year.
  • Bausch + Lomb Corporation reported quarterly inventory of 1.06 Billion USD for 2024 Q2, down -0.37% from previous quarter.
  • Bausch + Lomb Corporation reported quarterly inventory of 1.07 Billion USD for 2024 Q1, up 4.38% from previous quarter.

Annual Inventory Chart of Bausch + Lomb Corporation (2023 - 2019)

Historical Annual Inventory of Bausch + Lomb Corporation (2023 - 2019)

Year Inventory Inventory Growth
2023 1.02 Billion USD 63.69%
2022 628 Million USD 9.79%
2021 572 Million USD -7.14%
2020 616 Million USD 4.05%
2019 592 Million USD 0.0%

Peer Inventory Comparison of Bausch + Lomb Corporation

Name Inventory Inventory Difference
Alcon Inc. 2.32 Billion USD 55.713%
AptarGroup, Inc. 513.05 Million USD -100.369%
Baxter International Inc. 2.82 Billion USD 63.598%
Becton, Dickinson and Company 3.27 Billion USD 68.592%
Haemonetics Corporation 317.2 Million USD -224.084%
Envista Holdings Corp 258.8 Million USD -297.218%
ResMed Inc. 822.25 Million USD -25.023%
Teleflex Incorporated 626.21 Million USD -64.161%
Warby Parker Inc. 62.23 Million USD -1551.83%
West Pharmaceutical Services, Inc. 434.7 Million USD -136.485%